BioNTech SE (BNTX) Share-based Compensation (2019 - 2025)

BioNTech SE has disclosed Share-based Compensation across 7 years of filings, most recently posting $28.1 million for Q4 2025.

• Share-based Compensation for Q4 2025 came in at $28.1 million, up 11.71% year-over-year; the trailing twelve-month figure through Dec 2025 was $120.3 million (up 9.83% YoY), and the FY2025 annual result was $120.0 million, up 11.28% from the prior year.
• Share-based Compensation came in at $28.1 million for Q4 2025 at BioNTech SE, down from $32.6 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $73.6 million in Q3 2021 to a low of $20.87 in Q1 2021.
• The 5-year median for Share-based Compensation is $22.9 million (2022), against an average of $26.1 million.
• Peak annual rise in Share-based Compensation reached 269441191.15% in 2021, while the deepest fall reached 100.0% in 2021.
• BioNTech SE's Share-based Compensation stood at $23.5 million in 2021, then retreated by 3.42% to $22.6 million in 2022, then slumped by 32.54% to $15.3 million in 2023, then surged by 64.36% to $25.1 million in 2024, then advanced by 11.71% to $28.1 million in 2025.
• The last three Share-based Compensation figures came in at $28.1 million (Q4 2025), $32.6 million (Q3 2025), and $36.3 million (Q2 2025), per Business Quant data.